Aster DM Healthcare Puts Longevity in the Gap Between Illness Care and Wellness

Alisha Moopen, managing director and group CEO of Aster DM Healthcare, starts from a complaint about how medicine is organised. Care is designed around illness. People enter the system once something has already gone wrong. Wellth, the longevity and wellness business she co-founded within the group, was built for the people in between: those who want to remain well and are prepared to spend on health before a diagnosis forces the question.

That is where Moopen places longevity as a discipline. Conventional illness care sits on one side, wellness offerings on the other, and longevity occupies the ground between them. She is explicit that Wellth was not conceived as another wellness centre for the market but as a response to a structural gap.

The distinction she draws is between lifespan and healthspan. The global average gap between the two is roughly a decade, and most people spend their final eight to ten years in some form of illness or disability. Anti-ageing, in her framing, concerns slowing or reversing visible signs of ageing. Healthy ageing concerns function, resilience and quality of life. Wellth's anti-ageing work therefore looks at hormonal balance, nutritional status, stress and lifestyle rather than appearance alone. The promise is not that ageing can be stopped. It is that how well someone ages can be influenced.

The clinical offer is broad: diagnostics, NAD+ and IV therapies, ozone therapy, infrared and red-light therapy, hyperbaric oxygen therapy and cryotherapy. Moopen insists these are tools inside a strategy, not the strategy itself. Wellth does not begin with a treatment and then search for a reason to apply it. It begins with the individual. A wellness counsellor coordinates across functional medicine, nutrition, Ayurveda, Chinese medicine, physiotherapy, osteopathy, emotional wellbeing, yoga and Pilates, and assessments can include biological age and advanced biomarkers before findings are translated into a personal plan. The point of testing, she says, is a clearer understanding of one's health rather than an elaborate report. Integration, not any single therapy, is the differentiator, and integrative medicine is not positioned as a substitute for conventional care.

Thrive by myAster applies a similar logic at scale, measuring more than 100 biomarkers and health indicators in one sitting to flag problems before symptoms appear. Physicians then read the results against medical history, lifestyle, nutrition, stress, sleep, fitness and personal goals. Women's health gets its own architecture: Care for Her by Aster, launched in 2026, is organised across life stages from adolescence to post-menopause, alongside Elle by Medcare, so that a woman does not have to enter a different system each time her needs change. The case for that approach is visible in the numbers. A national health and nutrition survey found 22.4 percent of adults in the UAE living with obesity, 25.9 percent with high blood pressure and 54.2 percent with high cholesterol, while 2023 cancer registry data put breast cancer as the most diagnosed cancer among women.

The scale behind these programmes is what separates Aster's attempt from standalone longevity clinics. The group runs 16 hospitals, 128 clinics and 360 pharmacies across the Gulf, recording more than 20 million patient visits a year, with pharmacies carrying medicines, wellness products and pharmacist advice into daily life. Moopen argues that access to specialist medicine, diagnostics and clinical infrastructure is fundamental to a serious longevity proposition. The commercial bet is that a network built to treat illness can be turned toward preventing it, and that repeat contact through clinics and pharmacies gives preventive care somewhere to happen.

She expects the category to move quickly. Within five years, she predicts, longevity will shift from a specialised segment to a mainstream, preventive, data-driven form of medicine, away from one-off treatments and anti-ageing experiences toward long-term health management. Wellth's own ambition is to be a destination for lifelong optimisation that pairs modern diagnostics and functional medicine with nutrition, physical and emotional health, and traditional healing practices. The measure she returns to is simpler than any of that. The shift that matters is from asking how long people can live to asking how long they can stay healthy, independent, energetic and engaged.